Bioventix (GB:BVXP) has released an update.
Bioventix’s CFO, Bruce Hiscock, has increased his stake in the company by purchasing 300 ordinary shares at 3,330 pence each, reflecting confidence in the company’s prospects. This transaction, conducted on the AIM Market of the London Stock Exchange, showcases strategic insider activity that could pique investor interest in Bioventix’s future performance.
For further insights into GB:BVXP stock, check out TipRanks’ Stock Analysis page.
